Girls in Colombian town struck by mystery illness

by Joshua Goodman

A mystery illness has overwhelmed a small town in northern Colombia as scores of teenage girls have been hospitalized with symptoms that parents fear could be an adverse reaction to a popular vaccine against cervical cancer.

Authorities say they still don't know what caused more than 200 girls in El Carmen de Bolivar to come down with symptoms ranging from fainting to numbness in the hands and headaches. Some have hinted that the town of 95,000 near Colombia's Caribbean coast could be experiencing a rare case of .

Parents are on edge however because all the girls, ranging in ages from 9 to 16, were injected in recent months with the Gardasil. On Wednesday, residents marched peacefully to demand a thorough investigation.

Francisco Vega, the town's mayor and a trained physician, told The Associated Press that illnesses first appeared at the end of May and have been steadily increasing since. Over the weekend 120 were rushed to hospitals, collapsing the town's limited medical facilities. None of their symptoms were life-threatening and all have since been released, he said.

Echoing the assurances of national health and toxicology experts, who have traveled to the town to collect blood samples and investigate possible environmental hazards, he said there's no evidence the vaccine, which has undergone extensive testing and regulation globally, is to blame.

Meanwhile, Health Minister Alejandro Gaviria is criticizing hyped coverage by the media for stirring panic, saying concerns about their vaccine, which has been applied to 2.9 million women in Colombia, are baseless.

"On one side we have the weight of scientific evidence and on the other are opinions and moral prejudices," he told W Radio on Wednesday, adding the claims the lives of more than 3,000 women every year in Colombia.

Veronica Trulin, head of communications in Latin America for Merck, said all lots of the vaccine, including the ones sent to Colombia, meet all required quality and safety standards.

"We don't comment on speculation about our products," she said in an email.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Report: Teen HPV vaccination rate still lagging

Jul 25, 2013

(AP)—Disappointed health officials say only about half of teenage girls have gotten a controversial vaccine against cervical cancer—a rate that's changed little in three years.

1 in 5 boys got HPV shot in first year recommended

Aug 29, 2013

A new report offers a first look at how many boys are getting shots designed to protect girls from cervical cancer. Health officials say the number getting vaccinated so far is a good start.

Men's immunity could be key to new malaria drugs

Mar 12, 2014

(Medical Xpress)—A University of Alberta researcher's discovery about how malaria affects men could mean the difference between life and death for pregnant women in Colombia.

Three doses of HPV vaccine recommended against genital warts

Feb 11, 2014

Two doses of vaccine against human papillomavirus (HPV) provide good protection against genital warts, but three doses is better according to an extensive register study by researchers at Karolinska Institutet in Sweden. ...

Recommended for you

Sierra Leone streets deserted as shutdown begins

47 minutes ago

Sierra Leone's normally chaotic capital was transformed on Friday as residents were confined to their homes for the start of a three-day lockdown aimed at halting the deadly Ebola epidemic.

Sierra Leone launches controversial Ebola shutdown

2 hours ago

Sierra Leone on Friday launched a controversial three-day shutdown to contain the deadly spread of the Ebola virus, as the UN Security Council declared the deadly outbreak a threat to world peace.

Cooling of dialysis fluids protects against brain damage

15 hours ago

While dialysis can cause blood pressure changes that damage the brain, cooling dialysis fluids can protect against such effects. The findings come from a study appearing in an upcoming issue of the Journal of the American So ...

Two Ebola vaccines to be tested in Switzerland

15 hours ago

Clinical trials of two experimental vaccines against the deadly Ebola virus are due to begin soon in Switzerland, the country's Tropical and Public Health Institute said on Thursday.

User comments